Literature DB >> 11195059

Angiotensin type 2 receptors: potential importance in the regulation of blood pressure.

H M Siragy1, R M Carey.   

Abstract

The angiotensin type 2 receptor is one of two major angiotensin II receptors that has been identified, cloned and sequenced. The other major receptor, the angiotensin type 1 receptor, is thought to mediate most of the biological responses to the peptide. The angiotensin type 2 receptor is expressed heavily in fetal tissues, but only at a low level in the adult. Documented angiotensin type 2 receptor expression sites in the adult include kidney, heart and mesenteric blood vessels. The function of the angiotensin type 2 receptor is just beginning to be explored. Most of the evidence suggests that the angiotensin type 2 receptor mediates a vasodilator signalling cascade that includes bradykinin, nitric oxide and cyclic guanosine 5-monophosphate. At least some of the beneficial actions of angiotensin type 1 receptor blockade, such as hypotension, are mediated by stimulation of the angiotensin type 2 receptor. Several recent papers suggest that angiotensin type 2 receptors, presumably located in systemic blood vessels, mediate vasodilation and hypotension. The angiotensin type 2 receptor may be a new therapeutic target and candidate gene for the pathophysiology of hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11195059     DOI: 10.1097/00041552-200101000-00015

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  16 in total

Review 1.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

Review 2.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 3.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

4.  Systemic and renal hemodynamic effects of the AT1 receptor antagonist, ZD 7155, and the AT2 receptor antagonist, PD 123319, in conscious lambs.

Authors:  Mona L Chappellaz; Francine G Smith
Journal:  Pflugers Arch       Date:  2006-10-19       Impact factor: 3.657

Review 5.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

Review 6.  Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders.

Authors:  Mark A Perazella; John F Setaro
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 7.  Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis.

Authors:  Thomas A Morinelli; Louis M Luttrell; Erik G Strungs; Michael E Ullian
Journal:  Int J Biochem Cell Biol       Date:  2016-05-07       Impact factor: 5.085

Review 8.  Angiotensin II and abdominal aortic aneurysms.

Authors:  Alan Daugherty; Lisa Cassis
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

Review 9.  The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.

Authors:  Kambiz Kalantarinia; Helmy M Siragy
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 10.  Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2007-03       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.